melphalan hydrochloride injection, powder, lyophilized, for solution

FDA Drug Profile — Hepzato Kit

Drug Details

Generic Name
melphalan hydrochloride injection, powder, lyophilized, for solution
Brand Names
Hepzato Kit
Application Number
NDA201848
Sponsor
Delcath Systems, Inc.
NDC Codes
1
Dosage Forms
KIT
Routes
INTRA-ARTERIAL
Active Ingredients
N/A

Indications and Usage

1 INDICATIONS AND USAGE HEPZATO for injection, as a component of the HEPZATO KIT, is indicated as a liver-directed treatment for adult patients with uveal melanoma with unresectable hepatic metastases affecting less than 50% of the liver and no extrahepatic disease or extrahepatic disease limited to the bone, lymph nodes, subcutaneous tissues, or lung that is amenable to resection or radiation. HEPZATO is an alkylating drug indicated as a liver-directed treatment for adult patients with uveal melanoma with unresectable hepatic metastases affecting less than 50% of the liver and no extrahepatic disease, or extrahepatic disease limited to the bone, lymph nodes, subcutaneous tissues, or lung that is amenable to resection or radiation.( 1 )